Department of Population Health, NYU Grossman School of Medicine, New York, New York, United States of America.
National Institutes of Health, Bethesda, Maryland, United States of America.
PLoS One. 2024 Jul 3;19(7):e0298576. doi: 10.1371/journal.pone.0298576. eCollection 2024.
Quitting smoking may lead to improvement in substance use, psychiatric symptoms, and pain, especially among high-risk populations who are more likely to experience comorbid conditions. However, causal inferences regarding smoking cessation and its subsequent benefits have been limited.
We emulated a hypothetical open-label randomized control trial of smoking cessation using longitudinal observational data of HIV-positive and HIV-negative US veterans from 2003-2015 in the Veterans Aging Cohort Study. We followed individuals from the first time they self-reported current cigarette smoking (baseline). We categorized participants as quitters or non-quitters at the first follow-up visit (approximately 1 year after baseline). Using inverse probability weighting to adjust for confounding and selection bias, we estimated odds ratios for improvement of co-occurring conditions (unhealthy alcohol use, cannabis use, illicit opioid use, cocaine use, depressive symptoms, anxiety symptoms, and pain symptoms) at second follow-up (approximately 2 years after baseline) for those who quit smoking compared to those who did not, among individuals who had the condition at baseline.
Of 4,165 eligible individuals (i.e., current smokers at baseline), 419 reported no current smoking and 2,330 reported current smoking at the first follow-up. Adjusted odds ratios (95% confidence intervals) for associations between quitting smoking and improvement of each condition at second follow-up were: 2.10 (1.01, 4.35) for unhealthy alcohol use, 1.75 (1.00, 3.06) for cannabis use, 1.10 (0.58, 2.08) for illicit opioid use, and 2.25 (1.20, 4.24) for cocaine use, 0.78 (0.44, 1.38) for depressive symptoms, 0.93 (0.58, 1.49) for anxiety symptoms, and 1.31 (0.84, 2.06) for pain symptoms.
While a causal interpretation of our findings may not be warranted, we found evidence for decreased substance use among veterans who quit cigarette smoking but none for the resolution of psychiatric conditions or pain symptoms. Findings suggest the need for additional resources combined with smoking cessation to reduce psychiatric and pain symptoms for high-risk populations.
戒烟可能会改善物质使用、精神症状和疼痛,尤其是在更有可能出现合并症的高危人群中。然而,关于戒烟及其后续益处的因果推论一直受到限制。
我们使用 2003 年至 2015 年美国退伍军人老龄化队列研究中 HIV 阳性和 HIV 阴性退伍军人的纵向观察数据,模拟了一个假设的戒烟开放性随机对照试验。我们从个体首次报告当前吸烟(基线)时开始对其进行随访。我们将参与者分为戒烟者和非戒烟者,在第一次随访时(大约在基线后 1 年)。我们使用逆概率加权法来调整混杂因素和选择偏差,比较戒烟者和未戒烟者在第二次随访(大约在基线后 2 年)时同时改善共存疾病(不健康的饮酒、大麻使用、非法阿片类药物使用、可卡因使用、抑郁症状、焦虑症状和疼痛症状)的可能性,这些人在基线时就已经存在这些疾病。
在 4165 名符合条件的个体中(即基线时为当前吸烟者),419 名报告没有当前吸烟,2330 名报告在第一次随访时仍在吸烟。调整后的关联比值(95%置信区间)在第二次随访时戒烟与每种疾病改善之间的关联:不健康饮酒 2.10(1.01,4.35),大麻使用 1.75(1.00,3.06),非法阿片类药物使用 1.10(0.58,2.08),可卡因使用 2.25(1.20,4.24),抑郁症状 0.78(0.44,1.38),焦虑症状 0.93(0.58,1.49),疼痛症状 1.31(0.84,2.06)。
虽然我们的发现不能进行因果推断,但我们发现戒烟的退伍军人物质使用减少,但没有发现精神疾病或疼痛症状的缓解。研究结果表明,需要为高危人群提供额外的资源,结合戒烟来减少精神和疼痛症状。